Abstract 4492: BEZ235, a dual PI3K/mTOR inhibitor, enhances the activity of the multikinase inhibitor sorafenib in acute myeloid leukemia (AML)
Year: 2010
Type: conference-abstract
Source: Cancer Research
Institution: St. Jude Children's Research Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2027437226